Evidence map›Paper›PMID 31806660›Full record

ArticleDevelopment (Cambridge, England)2020

DUX is a non-essential synchronizer of zygotic genome activation.

Alberto De Iaco, Sonia Verp, Sandra Offner, Delphine Grun, Didier Trono

Abstract read
In one paragraph

Article in Development (Cambridge, England), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 66 papers.

0numbers the graph read from it
0cells of the map it votes in
66citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

66 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  13. Article
  14. Mouse and human embryonic genome activation initiate at the one-cell stage.Frontiers in cell and developmental biology · 2025
    Article
  15. Zscan4 mediates ubiquitination and degradation of the corepressor complex to promote chromatin accessibility in 2C-like cells.Proceedings of the National Academy of Sciences of the United States of America · 2024
    Article
  16. Review
  17. Article
  18. Article
  19. eLife · 2024
    Article
  20. Review

6 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Alberto De IacoSchool of Life Sciences, Ecole Polytechnique Fédérale de Lausanne (EPFL), 1015 Lausanne, Switzerland.ORCID 0000-0001-8388-4304
Sonia VerpSchool of Life Sciences, Ecole Polytechnique Fédérale de Lausanne (EPFL), 1015 Lausanne, Switzerland.
Sandra OffnerSchool of Life Sciences, Ecole Polytechnique Fédérale de Lausanne (EPFL), 1015 Lausanne, Switzerland.
Delphine GrunSchool of Life Sciences, Ecole Polytechnique Fédérale de Lausanne (EPFL), 1015 Lausanne, Switzerland.
Didier TronoSchool of Life Sciences, Ecole Polytechnique Fédérale de Lausanne (EPFL), 1015 Lausanne, Switzerland didier.trono@epfl.ch.ORCID 0000-0002-3383-0401

Funding

European Research Council 268721European Research Council 694658
6 · The paper itself

Abstract

Some of the earliest transcripts produced in fertilized human and mouse oocytes code for DUX, a double homeodomain protein that promotes embryonic genome activation (EGA). Deleting

Indexed as

Gene Expression Regulation, DevelopmentalGenomeAnimalsCrosses, GeneticDown-RegulationEmbryo, MammalianEmbryonic DevelopmentFemaleGenotypeHomeodomain ProteinsMaleMiceMice, TransgenicMouse Embryonic Stem CellsZygoteDux4 protein, mouseHomeodomain ProteinsDUXEmbryonic developmentZygotic genome activation

Identifiers

PMID31806660
PMCPMC7099940

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.